Baculoviral IAP Repeat-Containing 8 (BIRC8) (Middle Region) Peptide
BIRC8
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits ILP-2 (BIRC8)
- ILP-2 (BIRC8) (Baculoviral IAP Repeat-Containing 8 (BIRC8))
- Protein Region
- Middle Region
- Origine
- Humain
- Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- WMYSVNKEQL ARAGFYAIGQ EDKVQCFHCG GGLANWKPKE DPWEQHAKWY
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-BIRC8 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- ILP-2 (BIRC8) (Baculoviral IAP Repeat-Containing 8 (BIRC8))
- Synonymes
- ILP-2 Peptide, ILP2 Peptide, hILP2 Peptide, baculoviral IAP repeat containing 8 Peptide, BIRC8 Peptide
- Sujet
-
Alias Symbols: ILP2, ILP-2, hILP2
Protein Size: 236 - ID gène
- 112401
- NCBI Accession
- NM_033341, NP_203127
- UniProt
- Q6PIA0
-
Vous êtes ici:
